New anthropometric and biochemical models for estimating appendicular skeletal muscle mass in male patients with cirrhosis

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
NUTRITION, v.84, article ID 111083, 7p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: The use of easily accessible methods to estimate skeletal muscle mass (SMM) in patients with cirrhosis is often limited by the presence of edema and ascites, precluding a reliable diagnosis of sarcopenia. The aim of this study was to design predictive models using variables derived from anthropometric and/or biochemical measures to estimate SMM; and to validate their applicability in diagnosing sarcopenia in patients with cirrhosis. Methods: Anthropometric and biochemical data were obtained from 124 male patients (18-76 y of age) with cirrhosis who also underwent dual-energy x-ray absorptiometry (DXA) and handgrip strength (HGS) assessments to identify low SMM and diagnose sarcopenia using reference cutoff values. Univariate analyses for variable selection were applied to generate predictive decision tree models for low SMM. Model accuracy for the prediction of low SMM and sarcopenia (when associated with HGS) was tested by comparison with reference cutoff values (appendicular SMM index, obtained by DXA) and clinical sarcopenia diagnoses. The prognostic value of the models for the prediction of sarcopenia and mortality at 104 wk of follow up was further tested using Kaplan-Meier graphics and Cox models. Results: The models with anthropometric variables, alone and combined with biochemical variables, showed good accuracy (0.89 [0.83; 0.94] and 0.90 [0.84; 0.95], respectively) and sensitivity (0.72 [0.56; 0.85] and 0.74 [0.59; 0.86], respectively) and excellent specificity (0.96 [0.90; 0.99] and 0.97 [0.92; 0.99], respectively) in predicting SMM. Both models showed excellent accuracy (0.94 [0.89; 0.98], good sensitivity (0.68 [0.45; 0.86]), and excellent specificity (1.00 [0.96; 1.00]) in predicting sarcopenia. The models predicted mortality in patients with sarcopenia, with the likelihood of death sixfold greater relative to patients not predicted to have sarcopenia. Conclusions: Our simple and inexpensive models provided a practical and safe approach to diagnosing sarcopenia patients with cirrhosis along with an estimate of their mortality risk when other reference methods are unavailable.
Palavras-chave
Cirrhosis, Body composition, Sarcopenia, Muscle mass
Referências
  1. Anand AC, 2017, J CLIN EXP HEPATOL, V7, P340, DOI 10.1016/j.jceh.2017.11.001
  2. Belarmino G, 2018, JPEN-PARENTER ENTER, V42, P24, DOI 10.1177/0148607117701400
  3. Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142
  4. Bussab WO, 2006, ESTATISTICA BASICA
  5. Campillo B, 2006, GASTROEN CLIN BIOL, V30, P1137, DOI 10.1016/S0399-8320(06)73491-1
  6. Carnevale V, 2018, J AM MED DIR ASSOC, V19, P793, DOI 10.1016/j.jamda.2018.05.016
  7. Chang KV, 2019, J FORMOS MED ASSOC, V118, P833, DOI 10.1016/j.jfma.2018.09.011
  8. Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
  9. Cuppari L., 2019, GUIA NUTR CLIN ADULT, V4th
  10. D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013
  11. DiMartini A, 2013, LIVER TRANSPLANT, V19, P1172, DOI 10.1002/lt.23724
  12. Ebadi M, 2018, J HEPATOL, V69, P608, DOI 10.1016/j.jhep.2018.04.015
  13. European Assoc Study Liver, 2019, J HEPATOL, V70, P172, DOI 10.1016/j.jhep.2018.06.024
  14. FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
  15. Ginde SR, 2005, OBES RES, V13, P1232, DOI 10.1038/oby.2005.146
  16. Hanai T, 2016, HEPATOL RES, V46, P743, DOI 10.1111/hepr.12616
  17. Harrison J, 1997, TRANSPLANT INT, V10, P369, DOI 10.1007/s001470050072
  18. Johnson TM, 2013, NUTR CLIN PRACT, V28, P15, DOI 10.1177/0884533612469027
  19. Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563
  20. Kang SH, 2018, J CACHEXIA SARCOPENI, V9, P860, DOI 10.1002/jcsm.12333
  21. KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6
  22. Krell RW, 2013, LIVER TRANSPLANT, V19, P1396, DOI 10.1002/lt.23752
  23. Kroh A, 2019, HEPATOB PANCREAT DIS, V18, P28, DOI 10.1016/j.hbpd.2018.07.008
  24. Lohman TG., 1988, ANTHROPOMETRIC STAND
  25. Lucidi C, 2018, LIVER INT, V38, P851, DOI 10.1111/liv.13691
  26. McDowell Margaret A, 2008, Natl Health Stat Report, P1
  27. Merli M, 2013, METAB BRAIN DIS, V28, P281, DOI 10.1007/s11011-012-9365-z
  28. Moctezuma-Velazquez C, 2013, NUTRITION, V29, P1279, DOI 10.1016/j.nut.2013.03.017
  29. Molfino Alessio, 2017, Curr Nutr Rep, V6, P274, DOI 10.1007/s13668-017-0216-8
  30. Montano-Loza AJ, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.31
  31. Montano-Loza AJ, 2014, WORLD J GASTROENTERO, V20, P8061, DOI 10.3748/wjg.v20.i25.8061
  32. Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028
  33. Morgan MY, 2006, HEPATOLOGY, V44, P823, DOI 10.1002/hep.21358
  34. Musumeci G., 2017, J FUNCT MORPHOL KINE, V2, P40, DOI [10.3390/jfmk2040040, DOI 10.3390/JFMK2040040]
  35. Pirlich M, 2000, HEPATOLOGY, V32, P1208, DOI 10.1053/jhep.2000.20524
  36. Prado CMM, 2014, JPEN-PARENTER ENTER, V38, P940, DOI 10.1177/0148607114550189
  37. PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
  38. Putadechakum Supanee, 2012, ISRN Gastroenterol, V2012, P690402, DOI 10.5402/2012/690402
  39. R Core Team, 2021, R LANG ENV STAT COMP
  40. Ribeiro SML, 2018, NUTR ASSESSMENT THEO, V2nd
  41. Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051
  42. Santo Silva DD, 2019, CLIN NUTR ESPEN, V32, P56, DOI 10.1016/j.clnesp.2019.05.003
  43. Santos LP, 2019, JPEN-PARENTER ENTER, V43, P998, DOI 10.1002/jpen.1605
  44. Shawcross DL, 2010, HEPATOLOGY, V51, P1062, DOI 10.1002/hep.23367
  45. Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495
  46. Teiusanu Adriana, 2012, Maedica (Bucur), V7, P284
  47. Tsien C, 2014, J GASTROEN HEPATOL, V29, P1250, DOI 10.1111/jgh.12524
  48. Tsien C, 2013, EUR J GASTROEN HEPAT, V25, P85, DOI 10.1097/MEG.0b013e328359a759
  49. Yasutake K, 2018, ASIA PAC J CLIN NUTR, V27, P300, DOI 10.6133/apjcn.052017.04
  50. Yoshida M, 2015, J GASTROENTEROL, V50, P4, DOI 10.1007/s00535-014-1016-1